Pulmonary Edema Disease

DESCRIPTION

Pulmonary interstitial and/or alveolar fluid accumulation that results when the forces moving fluid out of the pulmonary capillary exceed the forces restraining that fluid

  • System(s) affected: Cardiovascular, Pulmonary
  • Genetics: Multifactorial
  • Incidence/Prevalence in USA:
    Approximately 150,000 persons per year in U.S. affected with non-cardiogenic pulmonary edema
  • Predominant age: Middle age and elderly
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Respiratory
    • Shortness of breath
    • Dyspnea with exertion
    • Orthopnea, paroxysmal nocturnal dyspnea
    • Cough, often accompanied by pink or blood-tinged and frothy sputum
    • Wheezing, rhonchi, gurgles
    • Moist, crepitant rales noted initially at bases and progressing to apices
    • Breathlessness, air hunger
    • Noisy respirations
    • Tachypnea
    • Dilated alae nasi
    • Inspiratory retraction of the intercostal spaces and/or supraventricular fossae
    • Cheyne-Stokes respirations
  • Cardiovascular
    • Tachycardia
    • Elevated jugular venous pulse
    • Increased P2
    • S3
    • S4
    • Nocturnal angina
    • Pulsus alternans or presence of valvular heart disease
  • General
    • Weakness, fatigue
    • Other symptoms depending on etiology
    • Anxiety
    • Diaphoretic, cold, ashen, or cyanotic skin
    • Lower extremity edema
CAUSES
  • Cardiogenic
    • Left heart failure
    • Ischemic heart disease
    • Acute myocardial infarction
    • Aortic and mitral valvular disease
    • Hypertensive heart disease
    • Cardiomyopathy
    • Volume overload
    • Arrhythmias
    • Endocarditis
    • Myocarditis
    • Congenital heart disease
    • Acute rheumatic fever and rheumatic heart disease
    • Septal defects
    • Cardiac tamponade
    • High cardiac output states (e.g., thyrotoxicosis, beriberi)
  • Non-cardiogenic
    • Shock
    • Multiple trauma
    • Infection/sepsis (especially pneumonia)
    • Liquid aspiration (e.g., drowning, gastric contents)
    • Inhaled toxic gases
    • Pulmonary lymphatic obstruction
    • Drug overdose (especially narcotics)
    • High-altitude illness
    • Pancreatitis
    • Embolism (thrombus, fat, air, amniotic fluid)
    • Neurogenic
    • Hematologic and immunologic disorders
    • Disorders associated with high negative pleural pressure
    • Radiation pneumonitis
    • Disseminated intravascular coagulation
    • Eclampsia
    • Decreased plasma oncotic pressure (e.g., hypoalbuminemia)
    • After cardioversion, anesthesia, or cardiopulmonary bypass
    • Oxygen toxicity
    • ARDS
    • Renal failure
RISK FACTORS
Dependent on etiology
LABORATORY
  • None specific for pulmonary edema; laboratory abnormalities (e.g., creatine kinase [CK], amylase, etc.) may point to underlying etiology
  • Hypoxemia
  • Hypocarbia
  • Respiratory alkalosis
  • Increased A-a gradient
  • Leukocytosis

Drugs that may alter lab results: Administered oxygen may complicate arterial blood gas interpretation
Disorders that may alter lab results: Underlying pulmonary disease from an unrelated etiology may complicate arterial blood gas interpretation

PATHOLOGICAL FINDINGS
  • Cardiogenic
    • Heavy, wet, subcrepitant lungs
    • Intra-alveolar granular pink precipitate
    • Alveolar microhemorrhages and hemosiderin-laden macrophages
    • "Brown induration," chronic passive congestion
    • Hypostatic bronchopneumonia
  • Non-cardiogenic
    • Heavy, firm, red, and boggy lungs
    • Interstitial and intra-alveolar edema, inflammation, fibrin deposition, hemorrhage, and patchy atelectasis
    • Hyaline membrane formation
    • Interstitial and intra-alveolar fibrosis
SPECIAL TESTS
  • Arterial blood gas
  • Electrocardiogram
  • Pulmonary function tests
  • Mixed venous oxygen saturation
IMAGING
  • Two-dimensional echocardiography with Doppler may be useful in some cases of cardiogenic pulmonary edema (e.g., valvular heart disease, systolic vs. diastolic dysfunction)
  • Chest x-ray (may be difficult or impossible to differentiate cardiogenic from non-cardiogenic pulmonary edema)
    • Cardiogenic chest x-ray; Interstitial edema, cardiomegaly, pulmonary venous redistribution, Kerley's B lines, alveolar edema (initially perihilar), pleural effusions (more common)
    • Non-cardiogenic chest x-ray; alveolar edema, cardiomegaly absent, pulmonary venous redistribution absent, pleural effusions less common
DIAGNOSTIC PROCEDURES
  • Swan-Ganz catheter may help differentiate cardiogenic from non-cardiogenic pulmonary edema
  • Cardiac catheterization - occasionally beneficial
APPROPRIATE HEALTH CARE

Generally inpatient or intensive care; outpatient for mildest forms

GENERAL MEASURES
  • Treat underlying condition
  • Patient sitting, with legs dangling
  • Oxygen
  • Rotating tourniquets or phlebotomy selectively
  • Mechanical ventilation, often requiring positive end-expiratory pressure support
  • Rapid reduction in altitude in cases of high altitude pulmonary edema
SURGICAL MEASURES

N/A

ACTIVITY

Bedrest in most cases

DIET

Low sodium diet

PATIENT EDUCATION
  • Low sodium, fluid restriction
  • Symptoms and signs of pulmonary edema
  • Importance of medical compliance
PREVENTION/AVOIDANCE

Compliance with medications and diet

POSSIBLE COMPLICATIONS
  • Death
  • Reversible or irreversible organ ischemia
  • Pulmonary fibrosis, particularly with non-cardiogenic pulmonary edema
EXPECTED COURSE AND PROGNOSIS
  • Dependent on underlying etiology
  • Mortality approximately 50-60% for non-cardiogenic pulmonary edema and up to 80% for cardiogenic shock
ASSOCIATED CONDITIONS

(see Causes)

AGE-RELATED FACTORS

Pediatric: Usually secondary to lung immaturity, congenital heart disease, or associated with trauma
Geriatric: Higher mortality
Others: N/A

PREGNANCY

Pulmonary edema may occur as a complication of tocolytic therapy with magnesium sulfate, terbutaline or ritodrine

OTHER NOTES

N/A

ABBREVIATIONS

ARDS = adult respiratory distress syndrome

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.